Marrying Data with Common Sense: Is it Safe to Amputate a Toe at Bedside in an Inpatient Unit?
Summary: January 25, 2026 post (likely by David Armstrong) discusses bedside amputation surgery (BAS) for delimited toe necrosis in diabetic foot units. Cites multi-center study (Feron et al., 2026) showing equivalent 6-month healing (53.8% BAS vs. 52.3% CAS) and re-op rates (24.5% vs. 16.9%). Advocates BAS for ~2/3 suitable cases to reduce delays, keep patients in specialized units, and optimize OR use for complex scenarios. Emphasizes common-sense selection (avoid severe ischemia <2 patent vessels, high CRP/infection); supports #ActAgainstAmputation by enabling faster limb-saving interventions.
Key Highlights:
- Data: Equivalent outcomes BAS vs. OR; no increased risk.
- Benefits: Streamlined care, resource efficiency.
- Limitations: Patient selection critical for success.
- Implications: Shifts paradigm toward bedside in DFU management to minimize major amputations.
Keywords: bedside amputation, diabetic foot, toe amputation, ActAgainstAmputation